MF
GILD icon

Montis Financial’s Gilead Sciences GILD Stock Holding History

Montis Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,480
Closed -$206K – 155
2026
Q1 		$206K Buy
+1,480
New +$207K 0.04% 146
2021
Q3 		– Sell
-3,359
Closed -$231K – 68
2021
Q2 		$231K Hold
3,359
– – 0.19% 64
2021
Q1 		$223K Hold
3,359
– – 0.21% 63
2020
Q4 		$220K Buy
+3,359
New +$203K 0.22% 65

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Montis Financial's GILD Position: Q2 2026 in Review

Montis Financial sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,480 shares — an estimated $206K sold.

Montis Financial first reported a position in GILD in Q4 2020 and held it in 4 quarters. The position peaked at $231K in Q2 2021. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Montis Financial reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Montis Financial sold 1,480 Gilead Sciences shares in Q2 2026, an estimated $206K.
  • Montis Financial first reported a position in Gilead Sciences in Q4 2020 and held it in 4 quarters.
  • Montis Financial's Gilead Sciences position peaked at $231K in Q2 2021.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Montis Financial's 13F filing for Q2 2026, filed 6 Aug 2026.